MedTrace Logo

CTC Pancreatic Adenocarcinoma

NCT02335151 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2019-12-13

No results posted yet for this study

Summary

Proportion of circulating tumor cells (CTC) in the postoperative phase after curative tumor removal of pancreatic cancer will be determined and correlated to the accordance of anesthesia (desflurane versus propofol)

Conditions

  • Adenocarcinoma
  • Circulating Tumor Cells
  • Pancreatic Neoplasms

Interventions

DRUG

Desflurane

Apply desflurane as anesthetic

Sponsors & Collaborators

  • Kantonsspital Winterthur KSW

    collaborator OTHER

  • Triemli Hospital

    collaborator OTHER

  • Cantonal Hospital of St. Gallen

    collaborator OTHER

  • University of Zurich

    lead OTHER

Principal Investigators

  • Beatrice Beck Schimmer, Prof. MD · University of Zurich

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2019-09-30
Completion
2019-10-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02335151 on ClinicalTrials.gov